ERBB2 and breast cancer: We then stratified the 1082 breast cancer patients into TNBC, HER-2, Luminal A and Luminal B subtypes and found that TGF-Β1 and TGF-Β2 mRNA expression was significantly elevated in TNBC patient samples compared to the other subtypes (Figure 2B).